Free Trial

Calidi Biotherapeutics (CLDI) Earnings Date, Estimates & Call Transcripts

Calidi Biotherapeutics logo
$1.45 -0.28 (-16.18%)
(As of 03:57 PM ET)

Calidi Biotherapeutics Latest Earnings Summary

Latest
Earnings Date
Nov. 12Estimated
Actual EPS
(Nov. 12)
-$0.65 Beat By $0.20
Consensus EPS
(Nov. 12)
-$0.85

Calidi Biotherapeutics announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.65, which beat analysts' consensus estimates of -$0.85 by $0.20. With a trailing EPS of $0.00, Calidi Biotherapeutics' earnings are expected to grow next year, from ($4.48) to ($0.88) per share.

Get Calidi Biotherapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Calidi Biotherapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLDI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLDI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Calidi Biotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.27-$0.27-$0.27
Q2 20241-$0.25-$0.25-$0.25
Q3 20241-$0.21-$0.21-$0.21
Q4 20241-$0.18-$0.18-$0.18
FY 20244($0.91)($0.91)($0.91)

Calidi Biotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024--$0.85-$0.65+$0.20-$0.65--
8/13/2024Q2 2024-$1.43-$1.40+$0.03-$1.40--
5/14/2024Q1 2024-$2.70-$2.00+$0.70-$0.20--
11/14/2023Q3 2023--$1.40 -$1.40-$0.14--

Calidi Biotherapeutics Earnings - Frequently Asked Questions

Calidi Biotherapeutics (NYSE:CLDI) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on CLDI's earnings history.

In the previous quarter, Calidi Biotherapeutics (NYSE:CLDI) reported ($0.65) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.20. Learn more on analysts' earnings estimate vs. CLDI's actual earnings.

Calidi Biotherapeutics (NYSE:CLDI) has a recorded annual revenue of $50,000.00.

Calidi Biotherapeutics (NYSE:CLDI) has a recorded net income of -$29.22 million. CLDI has generated $0.00 earnings per share over the last four quarters.

Calidi Biotherapeutics's earnings are expected to grow from ($4.48) per share to ($0.88) per share in the next year.

More Earnings Resources from MarketBeat



This page (NYSE:CLDI) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners